DelveInsight’s “Lupus Nephritis - Epidemiology Forecast To 2023” Report provides an overview of the disease and global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Lupus Nephritis from 2013-2023 for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan
Lupus Nephritis is the most common kidney disorder caused by the life-threatening autoimmune disease such as Systemic Lupus Erythematosus (SLE). It is a leading cause of morbidity and mortality in patients with Systemic Lupus Erythematosus. It leads to inflammation of small blood vessels which play an important role in filtering waste materials in kidney. It also involves the inflammation of glomeruli. It is observed that approximately 50% to 60% of adults and 30% to 80% of children with lupus develop Lupus Nephritis. Frequency of developing Lupus Nephritis decreases after 5 years of Systemic Lupus Erythematosus.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options. The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023. The Report includes the Sex Specific and Age Specific Prevalence of Lupus Nephritis of 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan)